Ancient herb takes on hypertension: new trial begins

NCT ID NCT07607275

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Yufeng Ningxin, a traditional Chinese medicine, can safely lower blood pressure in adults with mild hypertension. About 350 people aged 18-65 with untreated or washed-out high blood pressure will receive either the herbal tablet or a placebo for 8 weeks. The main goal is to see if it reduces systolic blood pressure more than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL (PRIMARY) HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Anzhen Hospital

    RECRUITING

    Beijing, China

  • Chinese PLA General Hospital

    RECRUITING

    Beijing, China

  • First Hospital of Shanxi Medical University

    NOT_YET_RECRUITING

    Taiyuan, China

  • Fuwai Hospital, Chinese Academy of Medical Sciences

    NOT_YET_RECRUITING

    Beijing, China

  • Inner Mongolia People's Hospital

    NOT_YET_RECRUITING

    Hohhot, China

  • Jiangsu Province Hospital

    NOT_YET_RECRUITING

    Nanjing, China

  • Longyan First Hospital

    NOT_YET_RECRUITING

    Longyan, China

  • Luohe Central Hospital

    RECRUITING

    Luohe, China

  • Peking University First Hospital

    NOT_YET_RECRUITING

    Beijing, China

  • Renmin Hospital of Wuhan University

    NOT_YET_RECRUITING

    Wuhan, China

  • The First Affiliated Hospital of Chongqing Medical University

    NOT_YET_RECRUITING

    Chongqing, China

  • The First Affiliated Hospital of Xiamen University

    RECRUITING

    Xiamen, China

  • The Second Affiliated Hospital of Dalian Medical University

    RECRUITING

    Dalian, China

  • The Second Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, China

  • The Second Affiliated Hospital of Shantou University Medical College

    NOT_YET_RECRUITING

    Shantou, China

  • Tianjin Kanghui Hospital

    RECRUITING

    Tianjin, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.